| Server IP : 192.169.170.185 / Your IP : 216.73.216.97 Web Server : Apache System : Linux p3plmcpnl495852.prod.phx3.secureserver.net 4.18.0-553.52.1.lve.el8.x86_64 #1 SMP Wed May 21 15:31:29 UTC 2025 x86_64 User : akhilnew ( 1712764) PHP Version : 5.6.40 Disable Function : NONE MySQL : ON | cURL : ON | WGET : ON | Perl : ON | Python : ON | Sudo : OFF | Pkexec : OFF Directory : /home/akhilnew/www/thepharmajournal/vol1issue11/ |
Upload File : |
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>
<meta name="Description" content="One of the components in the structure of the treatment of patients with coronary heart disease (CHD) is antianginal therapy, which is aimed primarily at preventing the development of myocardial ischemia and angina as its manifestation. This approach of treatment is aimed primarily at improving the quality of life in patients with angina " />
<meta name="keywords" content="Stable Angina, Hypertension, Nitratoresistance."/>
<title>Problem Of Nitratoresistance Occurrence And Ways Of It Overcoming</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
<meta name="Distribution" content="Global" />
<meta name="Author" content="Erwin Aligam - ealigam@gmail.com" />
<meta name="Robots" content="index,follow" />
<link rel="stylesheet" href="images/FreshMedia.css" type="text/css" />
<style type="text/css">
<!--
.style1 {
font-size: 16px;
color: #FF0033;
}
.style4 {color: #FF0033}
.style5 {color: #000000}
.style3 {
color: #FF0000;
font-weight: bold;
}
.style6 {
color: #000000;
font-weight: bold;
}
.style7 {color: #FFFFFF}
.style8 {color: #009966}
.style10 {color: #FF0033; font-weight: bold; }
-->
</style>
</head>
<script type="text/javascript">
var _gaq = _gaq || [];
_gaq.push(['_setAccount', 'UA-29701333-1']);
_gaq.push(['_trackPageview']);
(function() {
var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
})();
</script>
<body>
<!-- wrap starts here -->
<div id="wrap-out"><div id="wrap">
<!--header -->
<div id="header">
<h1 id="logo-text"><a href="http://www.thepharmajournal.com/" title="">The Pharma Innovation</a></h1>
<div id="nav">
<ul>
<li id="current"><a href="../index.html">Home</a></li>
<li><a href="../Editorial_Board.html">Editorial Board</a></li>
<li><a href="../archives.html">archives</a></li>
<li><a href="../instructions.html">instruction to authors</a></li>
<li></li>
<li><a href="../contact_us.html">contact us</a></li>
</ul>
</div>
<!--header ends-->
</div>
<!-- content-wrap starts -->
<div id="content-wrap">
<div id="main">
<h2 align="center" class="style6">Volume 1, Issue 11</h2>
<p> </p>
<h6 align="center" class="style1"> Problem Of Nitratoresistance Occurrence And Ways Of It Overcoming</h6>
<p> </p>
<p><span class="style10">Author:</span><span class="style5"> Nataliia Zozuliak<br />
Internal disease Department No 2, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Galytska stree - 2, Ukraine<br />
</span></p>
<p><span class="style10">Abstract:</span> <span class="style5">The aim of our study was to improve the treatment of patients with stable Angina Pectoris functional class III with Hypertension and prevention of nitratoresistance development with usage of antioxidant (Mexicor) and NO-donor (L-arginine). The study involved 63 patients with stable angina pectoris FC III with concomitant Hypertension. All patients were divided into two groups. Patients of I group received basic therapy, patients of group II - except basic therapy received Mexicor and L-arginin. The effectiveness of antianginal therapy was assessed by dynamic of clinical indicators, tolerance to physical activity, endothelial function and the level of oxidative stress. Influenced by Mexicor and L-arginine patients better upgraded clinical, hemodynamic and biochemical predictors of nitratoresistance compare with the influence of only basic therapy.</span></p>
<p><span class="style10">Download Full Article</span><span class="style10">:</span> <strong><a href="Issue_jan_2013/13.1.pdf">Click Here </a></strong></p>
<p> </p>
<h3><strong>Support Us</strong></h3>
<p class="style5">If you are interested in supporting our work and would like to contribute, you are
welcome to mail me at jpbr.anil@gmail.com or at info@thepharmajournal.com it will
be a great help and will surely be appreciated.</p>
<p class="style5"><a href="http://www.phytojournal.com/"><img src="images/headerphoto70.jpg" alt="Advertisement" width="532" height="146" /></a></p>
<p> </p>
</div>
<!-- sidebar starts -->
<div id="sidebar">
<h3 class="style4">ISSN 2277-7596</h3>
<p class="style4"><strong>Advertisement</strong><br />
</p>
<h3><a href="http://www.phytojournal.com/" target="_blank"><img src="images/cognosy.jpg" alt="Pharmacognosy Journal" width="206" height="146" longdesc="http://www.phytojournal.com/" /></a></h3>
<h3>Journal code(s)</h3>
<p class="style3"><strong><span class="style5">ISSN Number:</span> 2277-7695</strong></p>
<p class="style3"><span class="style5">CODEN Code:</span> PIHNBQ</p>
<p class="style3"><span class="style5">ZDB-Number:</span> 2663038-2 </p>
<p class="style3"><span class="style5">IC Journal ID:</span> 7725</p>
<h3>Sidebar Menu</h3>
<ul class="sidemenu">
<li><a href="http://www.thepharmajournal.com/">Home</a></li>
<li><a href="http://www.thepharmajournal.com/Editorial_Board.html">Editorial Board</a></li>
<li><a href="http://www.thepharmajournal.com/archives.html">Archives</a></li>
<li><a href="http://www.thepharmajournal.com/instructions.html">Instructions to Author</a></li>
<li><a href="http://www.thepharmajournal.com/indexing.html" title="Web Templates">Indexing and Abstracting</a></li>
<li><a href="http://thepharmajournal.com/publication_fee.html">Publication Fee</a></li>
<li><a href="http://www.thepharmajournal.com/contact_us.html" title="Web Templates">Contact Us</a></li>
</ul>
<h3>Wise Words</h3>
<p class="style5">"You will not be punished for your anger, you will be punished by your anger." by <span class="style4">Buddha</span>.
<!-- sidebar ends -->
</p>
</div>
<!-- content-wrap ends-->
</div>
<!-- footer starts here -->
<div id="footer-wrap">
<div id="footer-content">
<div class="col float-left space-sep">
<h3>Important Links</h3>
<p><a href="http://www.thepharmajournal.com/important_links.html" title="The Pharma Innovation">Important Links</a></p>
<p><a href="http://www.thepharmajournal.com/Payment_Options.html">Payment Options</a></p>
<p><a href="http://www.thepharmajournal.com/archives.html">Archives</a></p>
</div>
<div class="col float-left">
<h3> </h3>
<p><a href="http://www.thepharmajournal.com/Advertise_with_us.html" title="The Pharma Innovation">Advertise With Us</a></p>
<p><a href="http://www.thepharmajournal.com/certificate.html">Certificate</a></p>
<p><a href="http://www.thepharmajournal.com/Disclaimer.html" title="The Pharma Innovation">Disclaimer</a><a href="http://www.thepharmajournal.com/" title="The Pharma Innovation"></a></p>
<p> </p>
<p align="center"><span class="style5">© copyright 2012 <strong>The Pharma Innovation</strong></span></p>
</div>
<div class="col2 float-right">
<h3> </h3>
<p><a href="http://www.thepharmajournal.com/indexing.html" title="The Pharma Innovation">Abstracting and Indexing</a></p>
<p><a href="http://www.thepharmajournal.com/sitemap.html" title="The Pharma Innovation">Site Map</a></p>
<p><a href="http://www.thepharmajournal.com/contact_us.html" title="The Pharma Innovation">Contact us</a></p>
</div>
</div>
</div>
<div class="clearer"></div>
<!-- footer ends here -->
<!-- wrap ends here -->
</div></div>
</body>
</html>